Walleye Trading
BMY icon

Walleye Trading’s Bristol-Myers Squibb BMY Stock Holding History

Walleye Trading’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39M Sell
643,500
-662,800
-51% -$38.6M 0.07% 291
2025
Q4 		$70.5M Buy
1,306,300
+136,600
+12% +$6.57M 0.1% 207
2025
Q3 		$52.8M Buy
1,169,700
+157,000
+16% +$7.33M 0.08% 243
2025
Q2 		$46.9M Buy
1,012,700
+122,400
+14% +$6.01M 0.09% 245
2025
Q1 		$54.3M Buy
890,300
+278,900
+46% +$16.3M 0.13% 144
2024
Q4 		$34.6M Buy
611,400
+223,700
+58% +$12.5M 0.07% 290
2024
Q3 		$20.1M Buy
387,700
+166,200
+75% +$7.8M 0.04% 462
2024
Q2 		$9.2M Sell
221,500
-72,000
-25% -$3.22M 0.02% 725
2024
Q1 		$15.9M Sell
293,500
-351,400
-54% -$17.9M 0.03% 506
2023
Q4 		$33.1M Sell
644,900
-115,800
-15% -$6.08M 0.07% 270
2023
Q3 		$44.2M Buy
760,700
+344,300
+83% +$21.1M 0.12% 146
2023
Q2 		$26.6M Buy
416,400
+232,400
+126% +$15.6M 0.08% 218
2023
Q1 		$12.8M Sell
184,000
-252,200
-58% -$17.8M 0.03% 538
2022
Q4 		$31.4M Sell
436,200
-22,000
-5% -$1.66M 0.09% 241
2022
Q3 		$32.6M Sell
458,200
-85,500
-16% -$6.2M 0.1% 195
2022
Q2 		$41.9M Buy
543,700
+136,400
+33% +$10.4M 0.14% 116
2022
Q1 		$29.7M Buy
407,300
+186,900
+85% +$12.5M 0.1% 229
2021
Q4 		$13.7M Buy
220,400
+155,900
+242% +$9.15M 0.05% 440
2021
Q3 		$3.82M Sell
64,500
-51,700
-44% -$3.4M 0.01% 1090
2021
Q2 		$7.76M Buy
116,200
+60,500
+109% +$3.94M 0.03% 560
2021
Q1 		$3.52M Sell
55,700
-243,500
-81% -$15.2M 0.02% 894
2020
Q4 		$18.6M Sell
299,200
-62,000
-17% -$3.81M 0.08% 192
2020
Q3 		$21.8M Sell
361,200
-26,400
-7% -$1.59M 0.12% 114
2020
Q2 		$22.8M Sell
387,600
-413,300
-52% -$24.7M 0.15% 94
2020
Q1 		$44.6M Sell
800,900
-191,900
-19% -$11.7M 0.34% 17
2019
Q4 		$63.7M Buy
992,800
+779,900
+366% +$44.7M 0.44% 23
2019
Q3 		$10.8M Sell
212,900
-103,400
-33% -$4.86M 0.09% 181
2019
Q2 		$14.3M Sell
316,300
-1,143,900
-78% -$53.3M 0.12% 126
2019
Q1 		$69.7M Buy
1,460,200
+1,425,900
+4,157% +$71M 0.54% 16
2018
Q4 		$1.78M Sell
34,300
-315,000
-90% -$16.9M 0.01% 1159
2018
Q3 		$21.7M Buy
349,300
+202,800
+138% +$12M 0.11% 134
2018
Q2 		$8.11M Buy
146,500
+140,100
+2,189% +$7.57M 0.04% 370
2018
Q1 		$405K Sell
6,400
-237,500
-97% -$15.3M ﹤0.01% 2874
2017
Q4 		$14.9K Sell
243,900
-23,800
-9% -$1.49M 0.07% 195
2017
Q3 		$17.1K Buy
267,700
+167,600
+167% +$9.79M 0.08% 164
2017
Q2 		$5.58K Sell
100,100
-53,700
-35% -$2.92M 0.03% 512
2017
Q1 		$8.36K Buy
153,800
+64,400
+72% +$3.53M 0.06% 273
2016
Q4 		$5.23M Sell
89,400
-80,600
-47% -$4.41M 0.04% 412
2016
Q3 		$9.16M Buy
170,000
+134,100
+374% +$8.61M 0.06% 207
2016
Q2 		$2.64M Sell
35,900
-186,800
-84% -$13.2M 0.02% 821
2016
Q1 		$14.2M Buy
222,700
+210,900
+1,787% +$13.3M 0.13% 129
2015
Q4 		$814K Buy
11,800
+3,200
+37% +$211K 0.01% 1433
2015
Q3 		$512K Sell
8,600
-4,200
-33% -$266K ﹤0.01% 1541
2015
Q2 		$853K Buy
12,800
+2,800
+28% +$185K 0.01% 1240
2015
Q1 		$644K Sell
10,000
-20,500
-67% -$1.28M 0.01% 1303
2014
Q4 		$1.8M Sell
30,500
-18,300
-38% -$1.03M 0.02% 726
2014
Q3 		$2.5M Sell
48,800
-87,100
-64% -$4.35M 0.03% 341
2014
Q2 		$6.59K Buy
135,900
+66,500
+96% +$3.28M 0.09% 104
2014
Q1 		$3.6K Sell
69,400
-18,700
-21% -$995K 0.05% 242
2013
Q4 		$4.68M Hold
88,100
– – 0.05% 299
2013
Q3 		$4.08M Buy
88,100
+1,000
+1% +$43.9K 0.04% 317
2013
Q2 		$3.89M Buy
+87,100
New +$3.78M 0.04% 361

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Trading's BMY Position: Q4 2025 in Review

Walleye Trading sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 535,133 shares — an estimated $25.7M sold.

Walleye Trading first reported a position in BMY in Q2 2013 and held it in 36 quarters. The position peaked at $49.3M in Q3 2024. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Walleye Trading reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Walleye Trading sold 535,133 Bristol-Myers Squibb shares in Q4 2025, an estimated $25.7M.
  • Walleye Trading first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 36 quarters.
  • Walleye Trading's Bristol-Myers Squibb position peaked at $49.3M in Q3 2024.
  • 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Walleye Trading's 13F filing for Q4 2025, filed 13 Feb 2026.